What We Do

Our Work

Our work focuses on identifying projects that are dedicated to overcoming and abating pediatric brain cancer. To do this, IFF partners with, or supports, research labs at leading hospitals and universities around the country focused on the development of new therapeutic methodologies and treatments for pediatric brain tumors. IFF’s work is also focused on bringing public awareness to the severity of pediatric brain tumors and raises the funds so desperately needed to sponsor research.

Our Research

IFF takes a unique and innovative approach to pediatric cancer research. Specifically, IFF maximizes funds raised to be directed to pediatric brain tumor research by:

  • Keeping corporate overhead at less than 10% (according to Charity Watch: 40% overhead is reasonable; according to American Institute of Philanthropy: highly efficient, charitable organizations spend 25% on general administration)
  • Funding $0 indirect costs in research grants (indirect costs are those costs that cover multiple activities and that occur on a regular basis. They are usually administrative in nature. In other words they can’t be assigned to a particular product or service but are used to operate an organization as a whole such as accounting, office expenses, administrative salaries, etc.)
  • IFF employs 1 full-time paid staff member

Facts About Pediatric Brain Cancer

Our Research Partnerships

To date, Ian’s Friends Foundation has committed millions of dollars toward pediatric brain tumor research at the cutting-edge research institutions listed below.

Our Research Partnerships

Research establishing the feasibility of using interstitial infusion for treating pediatric brain stem gliomas. FDA approved clinical trial underway.
Research establishing the feasibility of using interstitial infusion for treating pediatric brain stem gliomas. FDA approved clinical trial underway.
Research focused on using new brain imaging techniques to improve diagnosis, prognosis and treatment of pediatric brain tumors.
Research focused on using new brain imaging techniques to improve diagnosis, prognosis and treatment of pediatric brain tumors.
Together, these Atlanta institutions pioneer the use of nanotechnology to gauge tumor size, stop tumor growth, and shrink tumors.
Together, these Atlanta institutions pioneer the use of nanotechnology to gauge tumor size, stop tumor growth, and shrink tumors.
Research focused on proteins which are active in pediatric low-grade gliomas. From this research, NYU hopes to better select molecular targeted drugs directed at these pathways.
Research focused on proteins which are active in pediatric low-grade gliomas. From this research, NYU hopes to better select molecular targeted drugs directed at these pathways.
Working to find biomarkers for brain tumors to make the diagnosis of tumor types easier, track their growth or even, no recurrence.
Working to find biomarkers for brain tumors to make the diagnosis of tumor types easier, track their growth or even, no recurrence.
Objective is to determine if an electrical stimulations regimen can arrest the division of dividing brain tumor cells.
Objective is to determine if an electrical stimulations regimen can arrest the division of dividing brain tumor cells.
Long-term goal is to improve understanding of tumor metabolism to design more effective therapies.
Long-term goal is to improve understanding of tumor metabolism to design more effective therapies.
New biorepository will provide the technology to grow and store cancer cells for use in brain tumor research.
New biorepository will provide the technology to grow and store cancer cells for use in brain tumor research.